Recent Overdose Experiences in a Community Sample of Military Veterans Who Use Opioids

Published date01 July 2017
DOI10.1177/0022042617701255
Date01 July 2017
Subject MatterArticles
https://doi.org/10.1177/0022042617701255
Journal of Drug Issues
2017, Vol. 47(3) 479 –491
© The Author(s) 2017
Reprints and permissions:
sagepub.com/journalsPermissions.nav
DOI: 10.1177/0022042617701255
journals.sagepub.com/home/jod
Article
Recent Overdose Experiences in
a Community Sample of Military
Veterans Who Use Opioids
Enrique R. Pouget1, Alex S. Bennett1, Luther Elliott1,
Andrew Rosenblum1, and Peter C. Britton2
Abstract
Rising rates of overdose mortality underscore the importance of understanding and preventing
overdose. We developed a seven-item scale for the assessment of nonfatal opioid-related
overdose experiences, adding items on others’ perceptions of whether the participant had
overdosed and whether an intervention was attempted to frequently used criteria. We
administered the scale to 240 primarily male and minority veterans, recruited using venue-
based and chain-referral sampling, who separated from the military post-9/11 and reported
current opioid use. The items were internally consistent, and correlated well with overdose
risk behaviors (r = .13-.45). The new scale detected overdose events in a significantly higher
proportion of participants (36.5%) than that using either self-report criterion (18.2%) or
difficulty breathing and losing consciousness criteria (23.8%). These experiences or perceptions
should be investigated to inform and better tailor the development of more effective overdose
prevention and response programs.
Keywords
opioids, overdose, drug use, drug poisoning, veterans
Drug poisoning or “overdose” has become the leading cause of injury death in the United States,
and has been increasing globally (Martins, Sampson, Cerda, & Galea, 2015; Rudd, Aleshire,
Zibbell, & Gladden, 2016; The Lancet, 2016). Most fatal overdoses involve the use of prescrip-
tion opioids (POs) or heroin, frequently combined with other drugs and/or alcohol (Johnson,
Hayes, Brown, Hoo, & Ethier, 2014; Rudd et al., 2016). The increase in opioid-related overdose
mortality is related in part to increased use of POs to treat chronic pain and diversion of these
drugs by individuals who may not have had them prescribed (Bohnert, Ilgen, et al., 2013; Rudd
et al., 2016). Pain patients who use POs may not necessarily be aware of overdose risks (Bohnert
et al., 2012; Bohnert, McCarthy, et al., 2013). Patients who are prescribed POs sometimes are
also prescribed other psychoactive drugs, such as benzodiazepines for anxiety, which can interact
with POs to increase overdose risk (Bohnert et al., 2012). In the United States, the overdose
1National Development and Research Institutes, Inc., New York, NY, USA
2Canandaigua VA Medical Center, NY, USA
Corresponding Author:
E. R. Pouget, Institute for Infectious Disease Research, National Development and Research Institutes, Inc., 71 W23rd
St., 4th fl., New York, NY 10010, USA.
Email: pouget@ndri.org
701255JODXXX10.1177/0022042617701255Journal of Drug IssuesPouget et al.
research-article2017

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT